Life sciences and biotech AI, cloud and IoT driving digital lab transformation as informatics market to hit $8.7bn by 2029 The global laboratory informatics market is experiencing a period of growth due to the acceleration of digital transformation and AI, as well as the rising use of data management tools in new markets Latest Content The latest solutions for automation and AI in lab software in 2025 Veeva Systems launches a new initiative to help life sciences companies automate tasks Sapio Sciences introduces biorepository management New technologies Solution Accelerators for biotech research Merz consolidates its R&D with a Life Sciences platform White papers Standardization of Analytical Data: Best Practices Standardization is critical to extracting the full potential of data. This White Paper offers a comprehensive guide to overcoming challenges and driving progress in analytical chemistry and beyond. Advancing the use of emerging computing infrastructure in Life Sciences RCH Solutions supports the adoption of novel computing technologies such as cloud, quantum, AI and edge computing paradigms through a co Boosting productivity of monoclonal antibody development using Chromeleon CDS: A collaboration to move biopharma forward Using the right tools is of paramount importance in the effort to advance tomorrow’s therapies. Webcasts On Demand Webinar: Consolidating computing resources can democratise research infrastructure More content Advancing the use of emerging computing infrastructure in Life Sciences Partnership aims to use AI to Identify novel cMET inhibitors for lung cancer Making sense of genomic data Google aiming to unpick protein ‘dark matter’ with AI Charles River Laboratories licenses Genedata Biologics Four bioscience predictions for 2022 Connecting biotech R&D teams for greater innovation, collaboration, and speed A digital transformation journey in the laboratory Visualising the future Panasas storage to support Australian cryo-EM research Labforward ramps up Series B financing Boosting productivity of monoclonal antibody development using Chromeleon CDS: A collaboration to move biopharma forward Pagination Previous page ‹ Previous Page 12 Next page Next ›
